|
Sign up now — watch Dec 4 No images? Click here 
The rise of investigator-initiated trialsThursday, December 4, 2025 | 11 AM – 1 PM ET Fast, cheap, and gaining momentum — investigator-initiated trials are upending the playbook Traditional clinical trials are expensive and slow. But in China, some companies are taking a different route: investigator-initiated trials, or IITs, that deliver quick reads on experimental drugs at a fraction of the cost. Now Western companies are paying attention — and adopting the approach themselves. What does this mean for the typical drug development process? And what are the trade-offs? On December 4, join Endpoints News for Clinical Trials Day '25, where our panel will unpack how IITs are reshaping trial strategy — and what it signals for the industry's future. SPONSORED BY 
Sponsorship opportunities available. |
